ALV-100

N/A

Report date: 2026/02/11 20:01:36

Base Information

Drug NameALV-100
Drug Alias NameALV-100ALV100
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsGlucose-Dependent Insulinotropic Polypeptide Receptor antagonists
TargetsGlucagon-like peptide 1 receptorGlucose-Dependent Insulinotropic Polypeptide Receptor
Therapy Area/IndicationsOverweightWeight LossObesity +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAlveus Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlveus Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsOverweightWeight LossObesity +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A